G6PD and hyperinsulinemic hypoglycemia, familial, 4: This toxicity is a significant public health concern because G6PD deficiency affects approximately 400 million people worldwide who live mostly in malaria-endemic countries, where the median G6PD deficiency allele prevalence was 8 % [33].